Volume | 710,232 |
|
|||||
News | (1) | ||||||
Day High | 37.755 | Low High |
|||||
Day Low | 36.25 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
PTC Therapeutics Inc | PTCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
37.575 | 36.25 | 37.755 | 36.47 | 37.20 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
12,823 | 710,232 | US$ 36.93 | US$ 26,231,636 | - | 17.53 - 45.68 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:01:48 | priorref | 144 | US$ 36.47 | USD |
PTC Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.79B | 76.61M | - | 1.07B | -626.6M | -8.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
PTC Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTCT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 39.92 | 40.69 | 36.25 | 38.19 | 949,309 | -3.45 | -8.64% |
1 Month | 31.96 | 40.69 | 30.705 | 35.07 | 909,474 | 4.51 | 14.11% |
3 Months | 30.71 | 40.69 | 23.995 | 30.55 | 880,485 | 5.76 | 18.76% |
6 Months | 21.38 | 40.69 | 21.10 | 28.54 | 1,003,432 | 15.09 | 70.58% |
1 Year | 42.49 | 45.68 | 17.53 | 28.75 | 1,035,223 | -6.02 | -14.17% |
3 Years | 39.42 | 59.84 | 17.53 | 36.35 | 772,697 | -2.95 | -7.48% |
5 Years | 39.85 | 70.82 | 17.53 | 40.82 | 719,260 | -3.38 | -8.48% |
PTC Therapeutics Description
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |